Yatırımcı.AI

BISTTRY11:54Live

Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.

Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.MEDTR

Main MarketChemicals, Petroleum, Rubber and Plastics
18.62−0.78 (−4.02%)
Volume
TRY 2M
Day range
18.58 – 19.38
Previous close
19.40
Market cap
TRY 2.2B

MEDTR Ratio Analysis: P/E, P/B, EV/EBITDA

35 key ratios for Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. (MEDTR) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.

Ratio Analysis

P/E66.43
P/B0.69
EV/EBITDA7.60
Dividend yield0.44%
Beta—
Earnings per share0.3 TL
Book value per share28.2 TL
EBITDA144.5M TL
Net profit−78.2M TL
Operating profit26.6M TL
Operating profit before finance costs34.4M TL
Net working capital1.5B TL
Gross margin33.71%
Operating margin1.95%
Net margin−5.75%
Return on assets0.92%
Return on equity1.14%
Current ratio3.76
Quick ratio2.50
Cash ratio—
Leverage ratio15.79
Debt to equity0.19
Debt to assets0.16
Fixed assets to equity0.60
Short-term debt share—
Interest coverage—
Receivables turnover0.65
Days sales outstanding562
Inventory turnover1.36
Days inventory outstanding268
Payables turnover2.33
Days payables outstanding157
Working capital turnover0.93
Equity turnover0.40
Asset turnover0.34

Frequently asked questions

MEDTR has a P/E ratio of 66.43, a P/B ratio of 0.69 and an EV/EBITDA of 7.60.

Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.